Gregory S. Martini - Jan 27, 2025 Form 3 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Financial Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Jan 27, 2025
Transactions value $
$0
Form type
3
Date filed
1/29/2025, 05:29 PM
Next filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IRWD Class A Common Stock 84.8K Jan 27, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRWD Employee Stock Options (Right to Buy) Jan 27, 2025 Class A Common Stock 3.31K $16.90 Direct F2
holding IRWD Employee Stock Options (Right to Buy) Jan 27, 2025 Class A Common Stock 1.59K $12.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, granted as an annual performance award, is presently exercisable in full.
F2 This option, granted as a new hire award, is presently exercisable in full.

Remarks:

Exhibit 24 - Power of Attorney